Actively Recruiting
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
Led by Centre Georges Francois Leclerc · Updated on 2025-02-18
80
Participants Needed
2
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Currently, the EXOMA2 study (NCT04614480) offers earlier and more comprehensive exome analysis in the management of cancer patients than EXOMA. Based on the active EXOMA2 patient file, the INFOGene study offers the opportunity to study patient-physician communication, to assess patient preferences with regard to different information modalities concerning theranostic exome analysis, and to reflect on information modalities to ensure optimal patient comprehension of the information provided. The qualitative cross-sectional study includes a dual observational and interventional component involving cancer patients. The patients will come from the EXOMA 2 active file at Dijon University Hospital and the CGFL.
CONDITIONS
Official Title
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient identified for inclusion in the EXOMA 2 study (exome analysis request)
- Available to receive different types of information
- Fluent in French
- No prior oncogenetic consultation
- Informed of the study objectives and given written non-objection to participate
- Authorizes audio recording of consultations and interviews
You will not qualify if you...
- Patient who refused to participate in the EXOMA2 study (for phase 3 patients only)
- Has a psychiatric, cognitive or neurological disorder that makes participation impossible
- Working in the field of genetics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre Georges-François Leclerc
Dijon, France, 21000
Actively Recruiting
2
CHU François Mitterand
Dijon, France, 21000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
OTHER
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here